Skip to main content
logo
Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
3.840
-0.080 (-2.04%)
At close: Sep 1, 2026, 4:00 PM EDT
3.840
0.00 (0.00%)
After-hours: Sep 1, 2026, 4:10 PM EDT

IMDX Revenue

Insight Molecular Diagnostics had revenue of $239.00K in the quarter ending June 30, 2026, a decrease of -53.86%. This brings the company's revenue in the last twelve months to $1.67M, down -60.77% year-over-year. In the year 2025, Insight Molecular Diagnostics had annual revenue of $4.06M with 115.58% growth.

Revenue (ttm)
$1.67M
Revenue Growth
-60.77%
P/S Ratio
75.25
Revenue / Employee
$28,793
Employees
58
Market Cap
125.66M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.06M2.17M115.58%
Dec 31, 20241.88M378.00K25.15%
Dec 31, 20231.50M545.00K56.89%
Dec 31, 2022958.00K-1.24M-56.41%
Dec 31, 20212.20M982.00K80.76%
Dec 31, 20201.22M--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Myriad Genetics806.60M
Castle Biosciences357.28M
Fulgent Genetics323.93M
MDxHealth114.02M
Biodesix102.94M
Burning Rock Biotech74.58M
Exagen71.12M
Precipio27.20M
Revenue Rankings

IMDX News

More News